Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2008-02-01Clinical Trial Update: Assess the Variability of Uni-Dimensional, Bi-Dimensional, and Volumetric CT Scan Measurement of Non-Small Cell Lung Cancer Tumors
A completed clinical study evaluating variability in uni-dimensional, bi-dimensional, and volumetric CT measurements of non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2008-01-29Clinical Trial Update: A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) [Phase 2]
A Phase 2 trial evaluated bevacizumab with chemotherapy or Tarceva (erlotinib) for recurrent or refractory non-small cell lung cancer and ha…
-
CLINICAL_TRIALS trial_result · 2008-01-28Clinical Trial Update: Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer [Phase 1]
A phase 1 vaccine therapy trial for patients with stage IB-IIIA non-small cell lung cancer undergoing surgery was terminated.
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing TLK286 (Telcyta) to Gefitinib in locally advanced or metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2008-01-10Clinical Trial Update: Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer [Phase 2]
Clinical trial update for a Phase 2 study evaluating 3D radiotherapy with or without erlotinib in localized non-small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-01-02Clinical Trial Update: LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy [Phase 2]
Phase 2 study LUCY evaluating treatment for non-small cell lung cancer in patients previously treated with chemotherapy has completed. The s…
-
CLINICAL_TRIALS trial_result · 2007-12-24Clinical Trial Update: A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating the CG8123 cancer vaccine with and without cyclophosphamide in advanced Non-Small Cell Lung Cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-24Clinical Trial Update: Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy [Phase 2]
This report covers a Phase 2 clinical trial evaluating a treatment for patients with non-small cell lung cancer who developed anemia due to …
-
CLINICAL_TRIALS trial_result · 2007-12-24Clinical Trial Update: ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial evaluating ABX-EGF in combination with paclitaxel and carboplatin for advanced non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating bevacizumab with carboplatin/paclitaxel and radiation in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine, cisplatin, and LY293111 in non-small cell lung cancer has completed. Sponsor: Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2007-12-19Clinical Trial Update: ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer [Phase 1]
A completed Phase 1 study evaluating gefitinib (Iressa) in combination with concurrent chemotherapy and radiation in locally advanced non-sm…
-
CLINICAL_TRIALS trial_result · 2007-12-19Clinical Trial Update: Phase II Iressa + Irradiation Followed by Chemo in NSCLC [Phase 2]
This update reports the completion of a Phase II trial evaluating Iressa (gefitinib) with irradiation followed by chemotherapy in non-small …
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Iressa 2nd Line Phase III Study in Japan [Phase 3]
A Phase 3 study of Iressa (gefitinib) as second-line therapy for non-small cell lung cancer in Japan has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-29Clinical Trial Update: A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer [Phase 2]
This document provides an update on a Phase 2 clinical trial of ABT-751 in patients with Non-Small Cell Lung Cancer, with the trial status n…
-
CLINICAL_TRIALS trial_result · 2007-11-20Clinical Trial Update: Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC [Phase 2]
A Phase 2 trial evaluates the efficacy and safety of cetuximab combined with cisplatin and gemcitabine as first-line therapy for advanced no…
-
CLINICAL_TRIALS trial_result · 2007-11-15Clinical Trial Update: Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC [Phase 2]
This Phase 2 trial evaluating alternating cycles of carboplatin/gemcitabine and carboplatin/paclitaxel for advanced non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing carboplatin plus gemcitabine versus gemcitabine alone in non-small-cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating neo-adjuvant gemcitabine and cisplatin in patients with earl…
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer [NA]
A completed clinical trial update for Iscar as a second-line treatment for advanced non-small cell lung cancer. The study identifier is NCT0…
-
CLINICAL_TRIALS trial_result · 2007-08-21Clinical Trial Update: Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated subcutaneous amifostine (Ethyol) for preventing radiochemotherapy-induced esophagitis and pneumonitis in patients …
-
CLINICAL_TRIALS trial_result · 2007-08-14Clinical Trial Update: Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating ABT-510 in combination with chemotherapy for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Iressa (gefitinib) as first-line therapy in chemonaive patients with inoperable non-small cell lung cancer has be…
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes [Phase 2]
A Phase 2 trial evaluating perioperative gemcitabine/cisplatin plus adjuvant chemoradiotherapy with weekly gemcitabine in node-positive non-…
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy [Phase 2]
A completed Phase 2 trial evaluating pemetrexed alone or in combination with gemcitabine in patients with advanced non-small cell lung cance…